Meena Subramanyam

Meena Subramanyam is a seasoned professional in the biopharmaceutical industry, currently serving as Vice President, Global Program Leader, and Portfolio Lead for Immune Cell Engagers at Takeda since May 2017. Prior roles at Takeda include Vice President and Global Program Leader for Takeda Oncology and Vice President and Global Program Lead for the Gastrointestinal Therapeutic Area Unit. Previously, Meena spent nearly two decades at Biogen, culminating in the role of Vice President of Translational Sciences and Technology & Biomarker Product Strategies. Early in the career, Meena held the position of Associate Director of Experimental Therapeutics at Ares Advanced Technology (Merck-Serono). Meena holds a Ph.D. in Microbiology and Immunology from Miami University and an MSc in Medical Microbiology from the University of Madras, Post-Graduate Institute of Medical Sciences.